Science Explorer Interactive view Map
Hospital / health system · Ashland · United States

Ashland Bellefonte Cancer Center

abcc.usROR OpenAlex
Research works
20
▲ 733% vs 2013–17
Citations
232
11.4 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
87%
world 28%

Not ranked overall: Ashland Bellefonte Cancer Center is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Ashland Bellefonte Cancer Center?

By fractional works in all years, weighted toward what it does more of than the world: Public Health, Epidemiology, ACE2 Receptor, Risk Factors, Pathogenesis, Pandemic, Diagnosis and SARS-CoV-2.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 14 words, with their numbers
  1. Epidemiology3▲ 3.7×23 topics
  2. Public Health3▲ 9.3×5 topics
  3. ACE2 Receptor2▲ 74×3 topics
  4. Diagnosis2▲ 7.0×13 topics
  5. Risk Factors2▲ 7.2×6 topics
  6. Treatment2▲ 5.5×13 topics
  7. Pandemic1▲ 15×4 topics
  8. Pathogenesis1▲ 12×7 topics
  9. SARS-CoV-21▲ 44×3 topics
  10. Chemotherapy1▲ 8.4×11 topics
  11. Genomic Analysis1▲ 19×2 topics
  12. Anthrax1▲ 288×1 topic
  13. Pathophysiology1▲ 18×4 topics
  14. Tularemia1▲ 288×1 topic

Which research topics does Ashland Bellefonte Cancer Center publish most on?

By volume in 2022–2025: Long-Term Effects of COVID-19, Drug-Induced Hepatotoxicity and Protection, Nephrotoxicity and Medicinal Plants and Cardiovascular Disease and Adiposity.

Long-Term Effects of COVID-19: 0 fractional worksDrug-Induced Hepatotoxicity and Protection: 0 fractional worksNephrotoxicity and Medicinal Plants: 0 fractional worksCardiovascular Disease and Adiposity: 0 fractional worksCOVID-19 Clinical Research Studies: 0 fractional works
NeurologyPharmacologyRadiology, Nuclear Medicine and ImagingCardiology and Cardiovascular Medicine1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Long-Term Effects of COVID-19 Neurology 0 works
  2. 2 Drug-Induced Hepatotoxicity and Protection Pharmacology 0 works
  3. 3 Nephrotoxicity and Medicinal Plants Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Cardiovascular Disease and Adiposity Cardiology and Cardiovascular Medicine 0 works
  5. 5 COVID-19 Clinical Research Studies Infectious Diseases 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available87.1%not open12.9%

World: 28% of research is openly available.

with international co-authors10.2%domestic only89.8%

World: 19% is written across borders.

How has Ashland Bellefonte Cancer Center's research output changed?

Output in 2018–2022 was 733% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Ashland

All research institutions in Ashland

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.